HCA Healthcare (NYSE:HCA) Raised to “Buy” at Bank of America

Bank of America upgraded shares of HCA Healthcare (NYSE:HCA) from a neutral rating to a buy rating in a research report sent to investors on Friday, Benzinga reports.

Other analysts have also recently issued reports about the company. Barclays raised their price target on HCA Healthcare from $145.00 to $155.00 and gave the company an overweight rating in a report on Wednesday, October 30th. ValuEngine upgraded HCA Healthcare from a sell rating to a hold rating in a research note on Wednesday, October 2nd. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The stock presently has a consensus rating of Buy and a consensus price target of $155.69.

Shares of NYSE HCA opened at $144.61 on Friday. The business has a 50-day moving average of $134.49 and a two-hundred day moving average of $129.36. The company has a market capitalization of $49.05 billion, a price-to-earnings ratio of 14.80, a price-to-earnings-growth ratio of 1.22 and a beta of 0.91. HCA Healthcare has a 1 year low of $110.31 and a 1 year high of $146.96.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, October 29th. The company reported $2.23 EPS for the quarter, beating the consensus estimate of $2.13 by $0.10. The firm had revenue of $12.69 billion during the quarter, compared to the consensus estimate of $12.48 billion. HCA Healthcare had a net margin of 6.98% and a negative return on equity of 173.49%. HCA Healthcare’s revenue for the quarter was up 10.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.16 EPS. Equities analysts anticipate that HCA Healthcare will post 10.53 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 2nd will be given a $0.40 dividend. The ex-dividend date is Friday, November 29th. This represents a $1.60 annualized dividend and a dividend yield of 1.11%. HCA Healthcare’s dividend payout ratio is presently 16.38%.

In related news, SVP Deborah M. Reiner sold 749 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $136.67, for a total value of $102,365.83. Following the sale, the senior vice president now owns 8,237 shares of the company’s stock, valued at approximately $1,125,750.79. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Jane D. Englebright sold 1,995 shares of the stock in a transaction on Friday, November 8th. The shares were sold at an average price of $137.50, for a total value of $274,312.50. Following the sale, the senior vice president now owns 10,480 shares in the company, valued at approximately $1,441,000. The disclosure for this sale can be found here. Over the last three months, insiders sold 40,571 shares of company stock worth $5,431,851. 2.70% of the stock is owned by corporate insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Steward Partners Investment Advisory LLC boosted its position in HCA Healthcare by 2.1% in the 2nd quarter. Steward Partners Investment Advisory LLC now owns 3,940 shares of the company’s stock valued at $532,000 after buying an additional 82 shares during the last quarter. Cibc Bank USA raised its holdings in HCA Healthcare by 1.7% in the third quarter. Cibc Bank USA now owns 5,656 shares of the company’s stock valued at $681,000 after acquiring an additional 96 shares in the last quarter. NEXT Financial Group Inc grew its holdings in HCA Healthcare by 32.1% during the 3rd quarter. NEXT Financial Group Inc now owns 424 shares of the company’s stock worth $51,000 after acquiring an additional 103 shares in the last quarter. Synovus Financial Corp grew its holdings in HCA Healthcare by 17.6% during the 3rd quarter. Synovus Financial Corp now owns 867 shares of the company’s stock worth $104,000 after acquiring an additional 130 shares in the last quarter. Finally, Brave Asset Management Inc. increased its position in shares of HCA Healthcare by 0.7% in the 3rd quarter. Brave Asset Management Inc. now owns 19,720 shares of the company’s stock worth $2,375,000 after purchasing an additional 144 shares during the last quarter. Institutional investors own 69.41% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: What is Call Option Volume?

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.